Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 3;10(21):5160. doi: 10.3390/jcm10215160

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the author.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Comparison of [¹⁸F]FDG PET/CT with anti-PD-L1 (18F-BMS-986192) and anti-PD-1 (89Zr-labeled Nivolumab) immuno-PET images in the same patient with NSCLC. Along the high glucose metabolism of the tumor in both lungs and mediastinal lymph nodes, a heterogeneous tracer uptake for 18F-BMS-986192 PET/CT and 89Zr-labeled Nivolumab PET/CT within and between tumors is demonstrated. Modified from Niemeijer AN et al. Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer. Nat Commun 2018;9:4664. [106]; Licensed under a Creative Commons license: http://creativecommons.org/licenses/by/4.0/) Last access date: 2 November 2021.